kw.\*:("Dihydrouracil dehydrogenase (NADP+)")
Results 1 to 7 of 7
Selection :
Purification and characterization of dihydropyrimidine dehydrogenase from human liverZHI-HONG LU; ZHANG, R; DIASIO, R. B et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 24, pp 17102-17109, issn 0021-9258Article
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusionHARRIS, B. E; SONG, R; SENG-JAW SOONG et al.Cancer research (Baltimore). 1990, Vol 50, Num 1, pp 197-201, issn 0008-5472Article
Circadian rhythm of rat liver dihydropyrimidine dehydrogenase: possible relevance to fluoropyrimidine chemotherapyHARRIS, B. E; SONG, R; YOU-JIAN HE et al.Biochemical pharmacology. 1988, Vol 37, Num 24, pp 4759-4762, issn 0006-2952Article
Stereochemistry of catabolism of the RNA base uracilGANI, D; YOUNG, D. W.Journal of the Chemical Society. Perkin transactions. I. 1985, Num 7, pp 1355-1362, issn 0300-922XArticle
Stereochemistry of the metabolism of the DNA base thymine and the drug 5-fluorouracilGANI, D; HITCHCOCK, P. B; YOUNG, D. W et al.Journal of the Chemical Society. Chemical communications. 1983, Num 16, pp 898-900, issn 0022-4936Article
Dihydropyrimidine dehydrogenase deficiency: a further caseWILCKEN, B; HAMMOND, J; BERGER, R et al.Journal of inherited metabolic disease. 1985, Vol 8, pp 115-116, issn 0141-8955, suppl. 2Article
Stereochemistry of catabolism of the DNA base thymine and of the anti-cancer drug 5-fluorouracilGANI, D; HITCHCOCK, P. B; YOUNG, D. W et al.Journal of the Chemical Society. Perkin transactions. I. 1985, Num 7, pp 1363-1372, issn 0300-922XArticle